Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Galera Therapeutics, Inc. (GRTX) had Free Cash Flow per Share of $-0.04 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.07M |
|
-- |
|
-- |
|
$1.14M |
|
$-1.14M |
|
$0.06M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.14M |
|
$-1.14M |
|
98.50M |
|
98.50M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$5.95M |
|
-- |
|
$0.10M |
|
$6.05M |
|
$0.35M |
|
-- |
|
$151.05M |
|
$151.40M |
|
$-147.94M |
|
$-145.35M |
|
$-145.35M |
|
75.46M |
|
| Cash Flow Statement Financials | |
$-3.69M |
|
-- |
|
$0.64M |
|
$8.29M |
|
$5.23M |
|
$-3.06M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.73% |
|
0.74% |
|
-17.77% |
|
0.74% |
|
$-1.93 |
|
|
Free Cash Flow per Share |
$-0.04 |
$-0.04 |
|